Press release
Pet Cancer Therapeutics Market to Surge Beyond US$ 332.6 Million by 2025
The Global Pet Cancer Therapeutics Market, by Therapy Type (Chemotherapy, Targeted Therapy, Combination Therapy, and Immunotherapy), by Pet Type (Cat, Dog, and Horse), by Mode of Administration (Oral, Intravenous, and Topical), by Application (Lymphoma, Mast Cell Cancer, Melanoma, Mammary and Squamous Cell Cancer, and Others) and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 183.3 million in 2017 and is projected to exhibit a CAGR of 7.7% over the forecast period (2017 – 2025), as highlighted in a new report published by Coherent Market Insights. The pet cancer therapeutics market is expected to gain significant traction with increasing global awareness regarding efficient and early diagnosis of pet cancers, adoption of novel therapies with the acclaimed safety profiles, and increasing R&D initiatives by research foundations.Request a SAMPLE copy of this Report: https://www.coherentmarketinsights.com/insight/request-sample/1284
Significant number of drugs in pipeline and growing veterinary healthcare expenditure to drive the global market growth
Market players engaged in pet therapeutics are focused on development, licensing, and commercialization of innovative therapeutics for dogs, cats, and horses. For instance, in 2017, Doxosphos Vet, a patented formulation of doxorubicin and XR17 technology by Oasmia Pharmaceuticals AB is currently under development for the treatment of lymphoma in dogs. The drug candidate was granted Minor Use & Minor Species (MUMS) designation by the FDA and is in clinical Phase II/dose confirmation trial. Also, in 2015, Rhizen Pharmaceuticals S.A. initiated Phase 2 study of RV1001, a novel oral selective inhibitor of PI3K delta for the treatment of lymphoma in dogs and was granted minor use designation by the FDA.
Moreover, increasing investments by pet owners in the developed economies is expected to propel the growth of market. According to an annual survey by the American Pet Products Association, 2015, the Americans spend an estimated US $15.4 billion on veterinary care annually.
Browse 55 Market Data Tables and 45 Figures spread through 195 Pages and in-depth TOC on “Pet Cancer Therapeutics Market”- Global Forecast to 2025
The veterinary pharmaceutical companies are focusing on strategic collaborations to develop and commercialize cancer treatments for companion animals. For instance, in 2017, Karyopharm and Anivive Lifesciences entered into an exclusive global license agreement to research, develop, and commercialize Verdinexor (KPT-335), a drug for the treatment of lymphoma, which is in phase 2b of clinical trials. The U.S. FDA Center for Veterinary Medicine (CVM) has found effectiveness and safety technical sections for Verdinexor complete to support conditional approval under a New Animal Drug Application (NADA) for the treatment of canine lymphoma and granted the Minor Use Minor Species (MUMS) designation to the drug candidate. Also, in 2016, Zenoaq, a Japan-based animal health company collaborated with Nexvet to form a research partnership for the development of monoclonal antibodies (mAbs) for canine cancer treatment.
Key Takeaways of the Pet Cancer Therapeutics Market:
The global pet cancer therapeutics market is expected to exhibit a CAGR of 7.7% over the forecast period, owing to the presence of high potential market, rising incidence of pet cancers, and increasing pet adoption rates in Europe, Asia Pacific, and Latin America
Among therapy type, chemotherapy segment holds a dominant position in the pet cancer therapeutics market, owing to the easy availability of the drugs, high recommendation by the veterinary doctors for opting chemotherapy, and high number of chemotherapeutic drugs present in the product portfolio of the manufacturers
Among pet type, dog segment holds a dominant position in the pet cancer therapeutics market owing to the higher cancer prevalence in the species as compared to the other pets and higher number of cancer treatments available for dogs in the global market
Among application, lymphoma segment holds a dominant position in the pet cancer therapeutics market, owing to the large number of patient pool diagnosed with lymphoma and a higher number of therapeutics approved for the treatment.
Some of the major players operating in the global pet cancer therapeutics market include Aratana Therapeutics, Inc., AB Science, Boehinger Ingelheim International GmbH, Zoetis, Zenoaq, Morphogenesis, Inc., VetDC, Inc., Karyopharm Therapeutics, Inc., Regeneus Ltd., Rhizen Pharmaceuticals SA, and Oasmia Pharmaceuticals AB
To know the latest trends and insights prevalent in the pet cancer therapeutics market, click the link below: https://www.coherentmarketinsights.com/market-insight/pet-cancer-therapeutics-market-1284
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit our news Website: http://www.coherentchronicle.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pet Cancer Therapeutics Market to Surge Beyond US$ 332.6 Million by 2025 here
News-ID: 941439 • Views: 662
More Releases from CMI - Pharmaceutical Research

Global Pulmonary Arterial Hypertension (PAH) Market - Pfizer, Inc., Actelion Pha …
Pulmonary hypertension or PH is a condition in which the blood pressure rises in the pulmonary artery, vein, or capillaries (collectively known as lung vasculature), which might lead to shortness of breath, fainting, leg swelling, and dizziness, among others. Pulmonary hypertension may be a relentless disease with a noticeable reduction in exercise tolerance. Pulmonary arterial hypertension or PAH indicates that the patient has high blood pressure in arteries that carry…

Betaxolol Market - Size, Share, Growth, Outlook, and Trends Analysis 2018–2026
Betaxolol is a racemic mixture and beta-adrenergic receptor inhibitor used to treat patients with chronic open-angle glaucoma or ocular hypertension. It was first approved by the U.S. Food and Drug Administration (FDA) in 1989, as an oral tablet. Betaxolol is used either alone or in combination with other medicines to lower down the pressure within the heart or eye. In the heart, Betaxolol decreases the cardiac contractility and rate selectively…

Gene Therapy Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026
Genes are composed of deoxyribonucleic acid (DNA), which contains essential information for producing proteins that are crucial for the optimal functioning of the body. Genetic disorder is the result of gene mutations in which proteins are made incorrectly. Gene therapy is intended to introduce healthy gene into damaged cells to counteract for abnormal genes or to make a protein of interest. Mutated gene causes missing of the important protein, with…

Cervical Cancer Drugs Market - Size, Share, Outlook, and Opportunity Analysis, 2 …
Cervical cancer develops in women’s cervix, and mainly affects sexually active women aged between 30 and 45. Cervical cancer often shows no symptoms in early stages. However, the death rate of cervical cancer can be significantly reduced with use of Pap test (Papanicolaou test): a screening procedure which can detect the changes in the cervix before the cancer develops. There are different types of cervical cancer, out of which two…
More Releases for Pet
Pet Travel Services Market 2020 PetSino IPATA Happy Tails Travel Pet Travel PetR …
With the slowdown in world economic growth, the Pet Travel Services industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Pet Travel Services market size to maintain the average annual growth rate of 15 from XXX million $ in 2014 to XXX million $ in 2019, BisReport analysts believe that in the next few years, Pet Travel Services market size will…
Pet Veterinary Diets Market 2019 Industry Dynamics - Mars, Farmina Pet Foods, Ni …
Recent market research study Global Pet Veterinary Diets Market 2019-2024 now available with Fior Markets provides a comprehensive market analysis based on past and current situation of the market. The report covers future trends, current growth drivers, thoughtful insights, facts, market valuation, competitive spectrum, regional share, and revenue predictions. The report shows the market size, share, business growth enhancers, and obstructers, prior and current trends being followed by the market.…
Recycled PET Market Share, Recycled PET Market Size, Recycled PET Market Trends, …
Scope of the Report:
This study provides an overview of the global recycled PET market, tracking one market segment across four geographic regions. The report studies key players, providing a five-year annual trend analysis that highlights market size, volume and share for North America, Europe, Asia Pacific (APAC) and Rest of the World (ROW). The report also provides a forecast, focusing on the market opportunities for the next five years for…
Pet Care Products Market is Booming Worldwide | Mars, Merrick Pet Care, Central …
HTF MI released a new market study on Global Pet Care Products Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. The research study provides…
Pet Furniture Market Is Booming Worldwide | Go Pet Club, North American Pet Prod …
HTF MI recently introduced Global Pet Furniture Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which are accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are Go Pet Club, North American Pet Products, MidWest Homes for Pets,…
Pet Utility Products Market 2018- Advanced Pet Products, IRIS USA Inc, Costal Pe …
This report studies the global market size of Pet Utility Products in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pet Utility Products in these regions.
Request a Sample of this Report@ http://www.orbisresearch.com/contacts/request-sample/2304884
This research report categorizes the global Pet Utility Products market by players/brands, region, type and application. This report also studies the global market status, competition…